HY8: (2~{S})-4-[[(2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[[9-[(2~{S},3~{R},4~{S},5~{S})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-6-yl]amino]propyl]amino]-2-azanyl-butanoic acid
HY8 is a Ligand Of Interest in 6QDX designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6QDX_HY8_A_301 | 65% | 1% | 0.115 | 0.918 | 5.53 | 2.16 | 14 | 16 | 1 | 0 | 100% | 1 |
| 6QDX_HY8_C_301 | 54% | 1% | 0.149 | 0.915 | 5.76 | 2.12 | 14 | 10 | 1 | 0 | 100% | 1 |
| 6QDX_HY8_B_301 | 53% | 1% | 0.149 | 0.909 | 5.64 | 2.36 | 14 | 12 | 1 | 0 | 100% | 1 |
| 6QDX_HY8_D_301 | 32% | 1% | 0.149 | 0.887 | 5.57 | 2.42 | 8 | 12 | 0 | 0 | 65% | 0.6458 |
